| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Anixa Biosciences, Inc. (ANIX) has 5 insiders with recent SEC Form 4 filings, including 9 buys and 1 sell. ANIX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 987.0K | $3.65M | +14.8K | |
| CEO | 640.8K | $2.37M | +10.0K | |
| CFO | 175.0K | $647.5K | - | |
| Dir | 135.0K | $499.5K | - | |
| Dir | 25.0K | $92.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 25, 2018 | Kumar Amit62 | Chief Executive Officer | Buy | 11,000 | $3.90 | $42,900.00 | +7.9% | |
| Oct 25, 2018 | Titterton Lewis H Jr65 | Director | Buy | 2,000 | $4.05 | $8,100.00 | +0.2% | |
| Sep 18, 2018 | Catelani Michael70 | COO &CFO | Buy | 2,250 | $4.45 | $10,012.50 | New | |
| Sep 14, 2018 | Kumar Amit62 | Chief Executive Officer | Buy | 3,000 | $4.08 | $12,240.00 | +2.2% | |
| Sep 14, 2018 | Titterton Lewis H Jr65 | Director | Buy | 5,000 | $3.98 | $19,900.00 | +0.6% | |
| Sep 13, 2018 | Kumar Amit62 | Chief Executive Officer | Buy | 4,112 | $3.96 | $16,283.52 | +3.2% | |
| Sep 13, 2018 | Kumar Amit62 | Chief Executive Officer | Buy | 3,000 | $3.84 | $11,520.00 | +2.3% | |
| Sep 12, 2018 | Kumar Amit62 | Chief Executive Officer | Buy | 4,480 | $3.99 | $17,875.20 | +3.6% | |
| Apr 9, 2018 | Williams Richard H | Director | Sell | 25,000 | $4.64 | $116,000.00 | -50.0% | |
| Jun 5, 2017 | Kumar Amit62 | Director | Buy | 10,000 | $0.90 | $9,000.00 | +8.7% |